A pharmacologic strategy is being considered for individuals with psychotic illness, taking into account efficacy, tolerability, and cost. The approach may involve assessment and management of agitation, as well as treatment targets and strategies for acute manic and mixed episodes of bipolar i disorder. The strategy's specifics and applications are being explored in the context of psychiatric treatment.